Home > Press Releases > Linde Gas Therapeutics in Germany has signed sales agreement with Airsonett: Faster international launch of new asthma treatment

Linde Gas Therapeutics in Germany has signed sales agreement with Airsonett: Faster international launch of new asthma treatment

Press Releases

26 August 08 15:06

Airsonett AB www.airsonett.com
Metallgatan 33 tel: +46 431 402530
262 72 Ängelholm fax: +46 431 14712
SWEDEN e-mail: info@airsonett-com
Ängelholm, Sweden August 26, 2008 PRESS RELEASE

The German gas and medical technology company Linde Gas Therapeutics has signed a sales agreement with the Swedish medical technology company Airsonett.

The agreement means that Linde Gas Therapeutics will be in charge of sales and marketing of Airsonett Airshower on the German market. For Airsonett the agreement will speed up the international launch of the product and that more asthma patients will get access to the treatment. Linde Gas Therapeutics in Germany, the leading provider of oxygen treatment, see that it is of strategic importance to widen their operations towards the asthma patients.

For more information, please contact: Dan Kristensson, CEO Airsonett AB tel. +46 70 379 65 72, e-mail dan.kristensson@airsonett.se

Michael Martinides, Business Development Manager Asthma, Linde Gas Therapeutics in Germany, tel.+49 151 16223844, e-post michael.martinides@linde-gas.com